FMT
LGND icon

First Mercantile Trust’s Ligand Pharmaceuticals LGND Stock Holding History

First Mercantile Trust’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,505
Closed -$68K – 915
2020
Q1 		$68K Buy
1,505
+67
+5% +$3.8K 0.01% 647
2019
Q4 		$94K Sell
1,438
-5
-0.3% -$334 0.01% 699
2019
Q3 		$90K Buy
1,443
+151
+12% +$9.48K 0.01% 721
2019
Q2 		$92K Buy
1,292
+2
+0.2% +$147 0.01% 663
2019
Q1 		$101K Buy
1,290
+144
+13% +$10.9K 0.02% 658
2018
Q4 		$97K Buy
1,146
+128
+13% +$13.6K 0.02% 663
2018
Q3 		$174K Sell
1,018
-329
-24% -$49.6K 0.03% 552
2018
Q2 		$174K Hold
1,347
– – 0.03% 548
2018
Q1 		$139K Sell
1,347
-3,504
-72% -$347K 0.03% 604
2017
Q4 		$414K Buy
4,851
+948
+24% +$82.2K 0.08% 311
2017
Q3 		$332K Buy
3,903
+1,803
+86% +$143K 0.06% 407
2017
Q2 		$159K Buy
2,100
+32
+2% +$2.24K 0.03% 618
2017
Q1 		$137K Sell
2,068
-144
-7% -$9.47K 0.02% 674
2016
Q4 		$140K Buy
2,212
+353
+19% +$22.3K 0.02% 672
2016
Q3 		$118K Sell
1,859
-369
-17% -$27.1K 0.02% 699
2016
Q2 		$166K Sell
2,228
-225
-9% -$16.7K 0.02% 643
2016
Q1 		$164K Sell
2,453
-224
-8% -$13.6K 0.02% 624
2015
Q4 		$181K Sell
2,677
-545
-17% -$33.6K 0.02% 668
2015
Q3 		$172K Buy
3,222
+561
+21% +$34K 0.02% 689
2015
Q2 		$167K Sell
2,661
-753
-22% -$41.1K 0.01% 732
2015
Q1 		$164K Buy
3,414
+1,378
+68% +$52.8K 0.01% 737
2014
Q4 		$68K Buy
+2,036
New +$66.2K 0.01% 912
2014
Q3 		– Sell
-10,695
Closed -$416K – 1167
2014
Q2 		$416K Sell
10,695
-321
-3% -$13K 0.03% 563
2014
Q1 		$462K Buy
11,016
+9,658
+711% +$403K 0.03% 619
2013
Q4 		$45K Buy
1,358
+595
+78% +$19.4K ﹤0.01% 991
2013
Q3 		$21K Buy
+763
New +$21.5K ﹤0.01% 1085

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return

First Mercantile Trust's LGND Position: Q2 2020 in Review

First Mercantile Trust sold out of Ligand Pharmaceuticals (LGND) in Q2 2020, closing a stake of 1,505 shares — an estimated $68K sold.

First Mercantile Trust first reported a position in LGND in Q3 2013 and held it in 26 quarters. The position peaked at $462K in Q1 2014. 262 funds tracked by Wall St. Rank hold LGND as of Q2 2020.

  • First Mercantile Trust reported no remaining Ligand Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • First Mercantile Trust sold 1,505 Ligand Pharmaceuticals shares in Q2 2020, an estimated $68K.
  • First Mercantile Trust first reported a position in Ligand Pharmaceuticals in Q3 2013 and held it in 26 quarters.
  • First Mercantile Trust's Ligand Pharmaceuticals position peaked at $462K in Q1 2014.
  • 262 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2020.

Based on First Mercantile Trust's 13F filing for Q2 2020, filed 10 Aug 2020.